# Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

> **NCT03205371** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1183 (actual)

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **BIOLOGICAL:** MenACYW conjugate vaccine
- **BIOLOGICAL:** MMR
- **BIOLOGICAL:** Varicella
- **BIOLOGICAL:** DTaP-IPV-HB-Hib
- **BIOLOGICAL:** PCV13

## Key facts

- **NCT ID:** NCT03205371
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-07
- **Primary completion:** 2018-07-19
- **Final completion:** 2018-07-19
- **Target enrollment:** 1183 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03205371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03205371, "Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03205371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*